Success Metrics

Clinical Success Rate
100.0%

Based on 20 completed trials

Completion Rate
100%(20/20)
Active Trials
1(4%)
Results Posted
20%(4 trials)

Phase Distribution

Ph not_applicable
6
23%
Ph phase_2
3
12%
Ph phase_3
2
8%
Ph early_phase_1
2
8%
Ph phase_4
8
31%
Ph phase_1
4
15%

Phase Distribution

6

Early Stage

3

Mid Stage

10

Late Stage

Phase Distribution25 total trials
Early Phase 1First-in-human
2(8.0%)
Phase 1Safety & dosage
4(16.0%)
Phase 2Efficacy & side effects
3(12.0%)
Phase 3Large-scale testing
2(8.0%)
Phase 4Post-market surveillance
8(32.0%)
N/ANon-phased studies
6(24.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

20 of 20 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

26

all time

Status Distribution
Active(2)
Completed(20)
Other(4)

Detailed Status

Completed20
unknown3
Suspended1
Active, not recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
26
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (8.0%)
Phase 14 (16.0%)
Phase 23 (12.0%)
Phase 32 (8.0%)
Phase 48 (32.0%)
N/A6 (24.0%)

Trials by Status

completed2077%
unknown312%
suspended14%
active_not_recruiting14%
not_yet_recruiting14%

Recent Activity

Clinical Trials (26)

Showing 20 of 26 trialsScroll for more
NCT07461103Phase 2

Effect of Topical Insulin on Healing Rate of Pemphigus Lesions

Completed
NCT05153395Early Phase 1

Impact of Intranasal Insulin on Sympathetic Activity and Cerebral Vasodilation

Suspended
NCT02879409Not Applicable

HbA1c Variability in Type II Diabetes

Active Not Recruiting
NCT05159453Phase 2

Dose Response Study of Transdermal Human Insulin in Patients

Not Yet Recruiting
NCT04857320Early Phase 1

Transdermal Insulin Response In Healthy Volunteers

Completed
NCT04834362Phase 4

Insulin for Hyperglycemia in Stroke Trial

Completed
NCT02109029Phase 1

A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat Tissue

Completed
NCT03651661Not Applicable

Pupillography as Screening Tool for Brain Insulin Resistance

Completed
NCT02620553Phase 1

Primary Intervention With Mucosal Insulin

Completed
NCT00264641Not Applicable

The Impact of Renin-angiotensin System on Brain Activation During Hypoglycaemia in Healthy Men, a PET Study

Completed
NCT00676819Phase 4

Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 Diabetes

Completed
NCT00567775Phase 2

Comparison of Human Insulin to Insulin Inhalation Solution in Children With Type 1 Diabetes

Completed
NCT00569400Phase 3

Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Type 1 Diabetes

Completed
NCT01448070Phase 1

Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Healthy Volunteers

Completed
NCT01467141Phase 4

Safety and Efficacy of Insulin Aspart in Children With Type 1 Diabetes

Completed
NCT00065130Phase 3

Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes

Completed
NCT00365170Phase 4

Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes

Completed
NCT00806936

Observational Study to Investigate the Efficacy and Safety of Human Insulin or Insulin Analogue Treatments in Type 2 Diabetes Subjects

Completed
NCT02468999Not Applicable

Influence of Central Nervous Insulin Action on Insulin Sensitivity of Peripheral Organs in Lean Versus Overweight Humans

Completed
NCT01797601Not Applicable

Insulin Sensitivity of the Human CNS System: fMRI Study With Intranasal Insulin Application

Completed

Drug Details

Intervention Type
DRUG
Total Trials
26